title: Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?
abstract: Clinical inertia is defined as the failure to establish appropriate targets and escalate treatment to achieve treatment goals. It accounts for a significant proportion of failure to achieve targets in the management of diabetes and contributes to up to 200,000 adverse diabetes- related outcomes per year. Despite a growing awareness of the phenomenon, and newer, better-tolerated agents for the control of diabetes, there has been little improvement over the last decade in the prevalence of clinical inertia. Although common-place in clinical practice, clinical inertia does not appear to affect clinical trials. There are lessons that may be translated from these randomised controlled trials to clinical practice, which that may improve the care for those with diabetes. Key amongst these interventions are good education, clear treatment strategy and more time for interaction between physician and patients, all of which appears to reduce clinical inertia as evidenced by the "placebo effect" of clinical trials. We plan to review here, the lessons that can be learnt from clinical trials and how these may translate to better care for people with diabetes.
authors.affiliation: Diabetes and Vascular Medicine, University of Exeter Medical School, Barrack Road, Exeter, EX2 5AX, UK, d.strain@exeter.ac.uk.
authors.forename: William David
authors.initials: WD
authors.lastname: Strain
authors.forename: Matthias
authors.initials: M
authors.lastname: Blüher
authors.forename: Païvi
authors.initials: P
authors.lastname: Paldánius
references.citation: Can J Cardiol. 2010 Jun-Jul;26(6):297-302
references.pmid: 20548975
references.citation: Diabetes Care. 2013 Nov;36(11):3411-7
references.pmid: 23877982
references.citation: Lancet. 2013 Aug 3;382(9890):409-416
references.pmid: 23706759
references.citation: Curr Med Res Opin. 2014 Feb;30(2):177-83
references.pmid: 24128339
references.citation: BMJ. 2013 Apr 09;346:f1515
references.pmid: 23571838
references.citation: Diabetes Res Clin Pract. 2011 Dec;94(3):352-63
references.pmid: 22153567
references.citation: J Clin Hypertens (Greenwich). 2011 Aug;13(8):613-20
references.pmid: 21806772
references.citation: J Gen Intern Med. 2007 Apr;22(4):453-8
references.pmid: 17372792
references.citation: Ann Fam Med. 2007 May-Jun;5(3):196-201
references.pmid: 17548846
references.citation: Diabetes Care. 2011 Feb;34(2):338-40
references.pmid: 21270191
references.citation: Diabetes Ther. 2013 Dec;4(2):175-94
references.pmid: 23990497
references.citation: Diabetes Care. 2004 May;27(5):1218-24
references.pmid: 15111553
references.citation: Nat Rev Endocrinol. 2013 Nov;9(11):635-6
references.pmid: 24042326
references.citation: Diabetes Care. 2013 Aug;36(8):2271-9
references.pmid: 23418368
references.citation: Diabetes Care. 2008 Jan;31(1):81-6
references.pmid: 17934153